International Journal of Clinical Pharmacy

, Volume 33, Issue 1, pp 111–123 | Cite as

Coronary heart disease: health knowledge and behaviour

  • Yazid N. Al Hamarneh
  • Grainne E. Crealey
  • James C. McElnayEmail author
Research Article


Objective To determine the current level of knowledge and understanding of CHD in the general public in Northern Ireland and to identify factors that are associated with higher knowledge levels. Setting Six provincial centres in Northern Ireland. Methods The data in the present study were collected using an interview administered questionnaire. 1,000 members of the general public were interviewed face-to-face. CHD knowledge was computed as a continuous variable, i.e. higher score represents better CHD knowledge. Main outcome measure CHD knowledge in the general public in Northern Ireland. Results Study respondents displayed limited knowledge and understanding of CHD. Study respondents who achieved higher CHD knowledge scores were more likely to report: exercising for 30 min three times or more per week, paying attention to their diet, being overweight, having a family history of CHD, living in a higher socioeconomic area (according to postcode) and having attended tertiary education. Respondents in the present study while recognising the role that community pharmacists had to play in helping patients manage their prescribed medicines, did not recognise the community pharmacists’ role in other aspects of CHD detection or management. Conclusion The deficit in CHD knowledge could translate into inadequate preventative behaviour patterns and suboptimal clinical outcomes. If community pharmacists wish to become increasingly involved in public health delivery relating to CHD they need to develop effective and accessible services and promote these to the public who at present do not recognise this role of the community pharmacist.


Coronary heart disease Northern Ireland Pubic knowledge Risk factors 



All the members of the general public who participated in this study.


No external funding.

Conflicts of interest

None declared.


  1. 1.
    Allender S, Peto V, Scarborough P, Kaur A, Rayner M. Coronary heart disease statistics [document on the internet]. 2008. Accessed on 11 May 2009. Available from:
  2. 2.
    Lindsay M, Gaw A. Coronary heart disease prevention. London: Elsevier Health Science; 2004. p. 10–14. ISBN 0 443 07117 9.Google Scholar
  3. 3.
    Glick M. Screening for traditional risk factors for cardiovascular disease. JADA. 2002;133:291–300.PubMedGoogle Scholar
  4. 4.
    Schenck-Gustafsson K. Risk factors for cardiovascular disease in women. Maturitas. 2009;63:186–90.PubMedCrossRefGoogle Scholar
  5. 5.
    Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fotmann SP, et al. AHA guide lines for primary prevention of cardiovascular disease and stroke: 2002 update: consensus panel guide to comprehensive risk reduction for adult patient without coronary or other atherosclerosis vascular disease. Circulation. 2002;106:388–91.PubMedCrossRefGoogle Scholar
  6. 6.
    Sug Yoon S, Heller RF, Levi C, Wiggers J, Fitzgerald PE. Knowledge of stroke risk factors, warning symptoms, and treatment among an Australian urban population. Stroke. 2001;32:1926–30.PubMedGoogle Scholar
  7. 7.
    Jafary FH, Aslam F, Mahmud H, Waheed A, Shakir M, Afzal A, et al. Cardiovascular health knowledge and behaviour in patient attendants at four tertiary care hospitals in Pakistan-a cause for concern. BMC Public Health. 2005;5:124–32.PubMedCrossRefGoogle Scholar
  8. 8.
    Thanavaro JL, Moore SM, Anthony M, Narsavage G, Delicath T. Predictors of health promotion behavior in women without prior history of coronary heart disease. ANR. 2006;19:149–55.PubMedGoogle Scholar
  9. 9.
    MacLean DR, Petrasovits A, Nargundkar M, Connelly PW, MacLeod E, Edwards A, et al. Canadian heart health surveys: a profile of cardiovascular risk. Survey methods and data analysis. Canadian heart health surveys research group. CMAJ. 1992;146:1969–74.PubMedGoogle Scholar
  10. 10.
    Potvin L, Richard L, Edwards AC. Knowledge of cardiovascular disease risk factors among the Canadian population: relationship with indicators of socioeconomic status. CMAJ. 2000;162:S5–11.PubMedCrossRefGoogle Scholar
  11. 11.
    Choiniere R, Lafotain P, Edwards AC. Distribution of cardiovascular disease risk factors by socioeconomic status among Canadian adults. CMAJ. 2000;162:S13–24.PubMedGoogle Scholar
  12. 12.
    Saeed O, Gupta V, Dhawan N, Sterja L, Shin JS, Ku M, et al. Knowledge of modifiable risk factors of coronary atherosclerotic heart disease (CASHD) among a sample in India. BMC Int Health Human Rights. 2009;9:2–7.CrossRefGoogle Scholar
  13. 13.
    Bell HM, McElnay JC, Hughes CM. Societal perspectives on the role of the community pharmacist and community based pharmaceutical services. J Soc Admin Pharm. 2000;17:119–28.Google Scholar
  14. 14.
    Wazaify M, Shields E, Hughes CM, McElnay JC. Societal perspectives of the over the counter medicines. Fam Pract. 2005;22:170–6.PubMedCrossRefGoogle Scholar
  15. 15.
    Mukattash TL, Millership JS, Collier PS, McElnay JC. Public awareness and views on unlicensed use of medicines in children. Br J Clin Pharmacol. 2008;66:838–45.PubMedCrossRefGoogle Scholar
  16. 16.
    Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and depression scale. An updated literature review. J Psychosom Res. 2002;52:69–77.PubMedCrossRefGoogle Scholar
  17. 17.
    British Heart Foundation. Our campaigns. [document on the internet]. 2009. Accessed 18 January 2010. Available from:
  18. 18.
    Michie S, Jochelson K, Markham WA, Bridle C. Low income groups and behaviour change interventions: a review of intervention content, effectiveness and theoretical frameworks. J Epidemiol Commun Health. 2009;63:610–22.CrossRefGoogle Scholar
  19. 19.
    Petricek G, Vrcic-Keglevic M, Vuletic G, Cerovecki V, Ozvacic Z, Murgic L. Illness perception and cardiovascular risk factors in patients with type 2 diabetes: cross-sectional questionnaire study. CMJ. 2009;50:583–93.PubMedGoogle Scholar
  20. 20.
    Brown CJ, Gottschalk M, van Ness PH, Fortinsky RH, Tinetti ME. Changes in physical therapy providers’ use of fall prevention strategies following a multicomponent behavioral change intervention. Phys Ther. 2005;5:394–403.Google Scholar
  21. 21.
    Kolodinsky J, Harvey-Berino JR, Berlin L, Johnson RK. Knowledge of current dietary guidelines and food choice by college students: better eaters have higher knowledge of dietary guidance. J Am Diet Assoc. 2007;107:1409–13.PubMedCrossRefGoogle Scholar
  22. 22.
    Hammond D, Fong GT, McNeill A, Borland R, Cummings KM. Effectiveness of cigarette warning labels in informing smokers about the risks of smoking: findings from the international tobacco control (ITC) four country survey. Tob Control. 2006;15:iii19–25.PubMedCrossRefGoogle Scholar
  23. 23.
    Thanavaro JL, Moore SM, Anthony MK, Narsavage G, Delicath T. Predictors of poor coronary heart disease knowledge level in women without prior coronary heart disease. JAANP. 2006;18:574–81.Google Scholar
  24. 24.
    Ali F, Laurin MY, Lariviere C, Tremblay D, Cloutier D. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. CJPJ. 2003;10:101–6.Google Scholar
  25. 25.
    Maguire TA, McElnay JC, Drummond A. A randomized controlled trial of a smoking cessation intervention based in community pharmacies. Addiction. 2001;96:325–31.PubMedCrossRefGoogle Scholar
  26. 26.
    Tsuyuki RT, Johnson JA, Teo KK, Simpson SH, Ackman ML, Biggs RS, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med. 2002;162:1149–55.PubMedCrossRefGoogle Scholar
  27. 27.
    Zillich AJ, Sutherland JM, Kumbera PA, Carter BL. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). JGIM. 2005;20:1091–6.PubMedCrossRefGoogle Scholar
  28. 28.
    McLean DL, McAlister FA, Johnson JA, King KM, Makowsky MJ, Jones CA, et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). Arch Intern Med. 2008;168:2355–61.PubMedCrossRefGoogle Scholar
  29. 29.
    Sinclair HK, Bond CM, Lennox AS, Silcock J, Winfield A. Knowledge of and attitudes to smoking cessation: the effect of stage of change training for community pharmacy staff. Health Bull. 1998;56:526–39.Google Scholar
  30. 30.
    Department of Health. Our health, our care, our say: a new direction for community services [document on the internet]. 2006. Accessed 20 January 2008. Available from:
  31. 31.
    British Heart Foundation. Northern Ireland coronary heart disease statistics 2009–10. [document on the internet]. 2010. Accessed 2 May 2010. Available from:
  32. 32.
    Northern Ireland Statistics and Research Agency. Population comparison with other countries of the United Kingdom by age and sex [document on the internet]. 2009. Accessed 15 August 2009. Available from:
  33. 33.
    O’Reilly D, Stevenson M. Selective migration from deprived areas in Northern Ireland and the spatial distribution of inequalities: implications for monitoring health and inequalities in health. Soc Sci Med. 2003;57:1455–62.PubMedCrossRefGoogle Scholar
  34. 34.
    Evandrou M, Falkingham J. Cigarette smoking and drinking behaviour in Northern Ireland 1986–2002: a cohort analysis [document on the internet]. 2004. Accessed 8 December 2008. Available from:

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  • Yazid N. Al Hamarneh
    • 1
  • Grainne E. Crealey
    • 2
  • James C. McElnay
    • 1
    Email author
  1. 1.School of PharmacyQueen’s University BelfastBelfastNorthern Ireland, UK
  2. 2.Clinical Research Support Centre, 1st Floor, Education and Research CentreRoyal HospitalsBelfastNorthern Ireland, UK

Personalised recommendations